1. Measurement and treatment research to improve cognition in schizophrenia: neuropharmacological aspects

   • Mark A. Geyer
   • Carol A. Tamminga

   Introduction 08 April 2004 Pages: 1 - 2

   

2. Targeting the dopamine D₁ receptor in schizophrenia: insights for cognitive dysfunction

   • Patricia S. Goldman-Rakic
   • Stacy A. Castner
   • Graham V. Williams

   Review 30 April 2004 Pages: 3 - 16

3. Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders

   • Bryan L. Roth
   • S. Mohammad Hanizavareh
   • Andrew E. Blum

   Review 02 December 2003 Pages: 17 - 24

4. Adrenergic targets for the treatment of cognitive deficits in schizophrenia

   • Amy F. T. Arnsten

   Review 19 December 2003 Pages: 25 - 31

   

5. The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia

   • Joseph T. Coyle
   • Guochuan Tsai

   Review 25 November 2003 Pages: 32 - 38

6. Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia

   • Bita Moghaddam

   Review 19 February 2004 Pages: 39 - 44

   

7. Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists

   • Joseph I. Friedman

   Review 19 February 2004 Pages: 45 - 53

8. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia

   • Laura F. Martin
   • William R. Kem
   • Robert Freedman

   Review 19 February 2004 Pages: 54 - 64

   

9. Pre-attentive processing and schizophrenia: animal studies

   • Bart A. Ellenbroek

   Review 04 December 2003 Pages: 65 - 74

   

10. Preattentional and attentional cognitive deficits as targets for treating schizophrenia

    • David L. Braff
    • Gregory A. Light

    Original Investigation 30 April 2004 Pages: 75 - 85

    

11. Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia

    • Y. Chudasama
    • T. W. Robbins

    Review 08 April 2004 Pages: 86 - 98

    

12. Hippocampal function in cognition

    • J. David Sweatt

    Review 02 March 2004 Pages: 99 - 110

    

13. Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia

    • Stacy A. Castner
    • Patricia S. Goldman-Rakic
    • Graham V. Williams

    Review 20 January 2004 Pages: 111 - 125

14. Pharmacological manipulation of human working memory

    • Deanna M. Barch

    Review 30 January 2004 Pages: 126 - 135

15. Practice, learning, and the likelihood of making an error: how task experience shapes physiological response in patients with schizophrenia

    • Henry H. Holcomb

    Review 13 March 2004 Pages: 136 - 142

16. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction

    • David A. Lewis
    • David W. Volk
    • Takanori Hashimoto

    Review 09 December 2003 Pages: 143 - 150

    

17. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications

    • Paul J. Harrison

    Review 06 March 2004 Pages: 151 - 162